Key result
Advanced imaging detects asymptomatic abnormalities that complicate differentiating ACM from healed viral myocarditis in athletes.
Why the study?
Differentiating arrhythmogenic cardiomyopathy from healed viral myocarditis in competitive athletes is challenging, especially with advanced imaging detecting abnormalities in asymptomatic individuals.
Case Report (n=1)
Distinguishing healed myocarditis from arrhythmogenic cardiomyopathy in competitive athletes requires multimodality evaluation and shared decision-making for safe return-to-play decisions.
Answers are grounded in this paper and cite their sources.
Clinicians should integrate multimodal testing for athletes with myocardial abnormalities; leaves open refined criteria to distinguish arrhythmogenic cardiomyopathy from healed myocarditis.
BACKGROUND: Differentiating arrhythmogenic cardiomyopathy (ACM) from healed viral myocarditis in competitive athletes is challenging, particularly as advanced imaging increasingly detects myocardial abnormalities in asymptomatic individuals. CASE SUMMARY: A 26-year-old professional football player was found to have lateral and inferior T-wave inversions during preseason screening. He was asymptomatic with normal biomarkers and excellent exercise capacity. Cardiac magnetic resonance demonstrated left ventricular enlargement with mildly reduced systolic function and 2 discrete regions of nonischemic replacement fibrosis without active inflammation. Ambulatory monitoring showed a very low ectopic burden without ventricular arrhythmias, and comprehensive cardiomyopathy genetic testing was negative. Multidisciplinary shared decision-making supported conditional clearance with ongoing surveillance and emergency preparedness. DISCUSSION: This case highlights diagnostic uncertainty between ACM and postinflammatory scar, underscoring the necessity of contextual imaging interpretation and nuanced multimodal evaluation. TAKE-HOME MESSAGES: Distinguishing healed myocarditis from ACM in competitive athletes remains a significant diagnostic challenge, particularly when cardiac magnetic resonance demonstrates nonischemic myocardial fibrosis in otherwise asymptomatic individuals. Multimodality evaluation, longitudinal follow-up, and shared decision-making are essential to establish the correct diagnosis, guide risk stratification, and inform safe return-to-play decisions.
No takes yet. Share an insight, caveat, or question.
DiCaro et al. (2026) conducted a case report in Arrhythmogenic cardiomyopathy vs viral myocarditis (n=1). Multimodality evaluation and shared decision-making was evaluated on Diagnosis and return-to-play decision. Multidisciplinary shared decision-making and multimodality evaluation supported conditional clearance for a 26-year-old athlete with diagnostic uncertainty between ACM and healed myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: